Positron-Emission Tomography With Vesicular Monoamine Transporter Ligand ([18F]-DTBZ) In Healthy Elderly And Young Subjects

Chang Gung Memorial Hospital25 enrolled

Overview

A total 25 healthy subjects will be included in this study. Subjects between 20 and 80 years of age may be eligible for this study. Candidates are screened with a medical history and physical examination, and blood test.

The primary objective of this protocol is to assess the possible age-dependent decline in striatal 18F-DTBZ uptake of healthy subjects. This study is expected to be completed in a period of 2 years.

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

Conditions

Healthy

Interventions

18F-DTBZ AV-133DRUG

Eligibility

Sex: ALLMin age: 20 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: 1. Male or female age 20 years to 80 years. 2. Subjects without significant neuropsychiatric disorder after evaluation by Neurologist. 3. Subjects who provide a written informed consent prior to study entry. If the subject is incapable of informed consent, the caregiver may consent on behalf of the subject (the subject must still confirm assent). Exclusion Criteria: 1. Pregnancy and breast feeding. 2. Significant recent (within 6 months) history of neurological (including stroke and brain trauma) or psychiatric disorder. 3. Alcohol or substance abuse within last year. 4. Parkinson's disease or other brain degenerative disease (spinocerebellar ataxia, Wilson's disease, hydrocephalus, multiple infarction, history of severe head injury or intracranial operation. 5. Unable to stay still in the MRI or PET scanner for 30 minutes.

Outcomes

Primary Outcomes

Age-Dependent Change in Striatal 18F-DTBZ Uptake of Healthy Subjects.

Time frame: two years

Secondary Outcomes

The Test/Retest 18F-DTBZ PET Measurements of VMAT2 Binding in Healthy Subjects.

Time frame: two years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.